Published on 14 Nov 2022 on Simply Wall St. via Yahoo Finance
One thing we could say about the analysts on Invacare Corporation (NYSE:IVC) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon.
Following the latest downgrade, the two analysts covering Invacare provided consensus estimates of US$735m revenue in 2023, which would reflect a small 6.6% decline on its sales over the past 12 months. The loss per share is anticipated to greatly reduce in the near future, narrowing 36% to US$1.34. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$826m and losses of US$0.87 per share in 2023. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a serious cut to their revenue forecasts while also expecting losses per share to increase.
Check out our latest analysis for Invacare